欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球高血压药物市场报告(2016-2020年)

Global Hypertension Drugs Market 2016-2020

加工时间:2016-04-24 信息来源:EMIS 索取原文[87 页]
关键词:高血压;血压高(BP);血管的内壁;施加的压力;PAH;系统性高血压
摘 要:Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as: PAH Systemic hypertension (commonly referred to as hypertension)
目 录:

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Key buying criteria

PART 05: Cardiovascular drugs market

Global pharmaceuticals market

Global cardiovascular drugs market

PART 06: Overview: Hypertension

Systemic hypertension

PAH

PART 07: Epidemiology and economic burden

Economic burden

PART 08: Pipeline portfolio

PART 09: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 10: Market segmentation by type

Global systemic hypertension drugs market

Global PAH drugs market

PART 11: Market segmentation by drug class

Systemic hypertension

PAH

PART 12: Geographical segmentation

Global hypertension drugs market by geographical

segmentation 2015-2020

Hypertension drugs market in Americas

Hypertension drugs market in EMEA

Hypertension drugs market in APAC

PART 13: Market drivers

Growing older population

Rise in sedentary lifestyle

High prevalence of chronic conditions

Patient assistance programs

PART 14: Impact of drivers

PART 15: Market challenges

Patent expiries of major drugs

Adverse effects

Poor patient compliance

Availability of alternative therapies

PART 16: Impact of drivers and challenges

PART 17: Market trends

Increase in awareness

Increased focus on combination therapies

Intense competition among vendors

Strategic alliances

PART 18: Vendor landscape

Competitive scenario

Market share 2015

Novartis

Daiichi Sankyo

Actelion Pharmaceuticals

Boehringer Ingelheim

Sanofi

AstraZeneca

Other prominent vendors

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio

© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服